Bio-Fields
Board
2 directors, 1 in day-to-day management, 1 auditor, no change since October 2026Deed of 09-10-2026 reappointed as statutory auditor acts as permanent representative · General meeting of 19-09-2025
Director, permanent representative
since 01-10-2025
6-year term from 2025
also on the board of 3 other companies
listed in the 2025 annual accounts, filed on 06-10-2026
Director and managing director, permanent representative
director since 01-10-2025
managing director appointed by deed of 30-10-2025
6-year term from 2025, term without a fixed end
also on the board of 3 other companies
listed in the 2025 annual accounts, filed on 06-10-2026
Statutory auditor, permanent representative
current term since 19-09-2025
3-year term from 2025
listed in the 2025 annual accounts, filed on 06-10-2026
- Signing authorityThe articles say who may bind the company, for example by signing a contract.
- “6. om artikel 20 van de statuten betreffende de vertegenwoordiging van de vennootschap aan te passen waarbij de zin na punt 1. wordt…”deed of 06-10-2022
Permanent representatives 2
Mandates through the years
8 names, the dashed line is todayDirector
Director, Managing director
Statutory auditor
Managing director
Director
Director
Director
Director
LeadershipBoardEarlierRest of the termend not dated
Mandates as a list
-
- Director, from 01-10-2025 to date
-
- Director, from 01-10-2025 to date
- Managing director, appointed by deed of 30-10-2025, still in office
-
- Statutory auditor, from 21-11-2022 to date
-
- Director, from 23-01-2020 to 30-10-2025
- Managing director, appointed by deed of 29-01-2020, until 30-10-2025
-
- Director, from 11-03-2022 to 30-10-2025
-
- Director, appointed by deed of 29-01-2020, until 30-05-2022
-
- Director, appointed by deed of 30-05-2022, until 30-05-2022
-
- Chair, appointed by deed of 29-01-2020, ended, last mentioned on 29-01-2020
- Director, appointed by deed of 29-01-2020, until 30-05-2022
Control
Parent
Equity €17.5m
Profit €1.1m in 2025 (profit €546,218 in 2024)
Source: accounts 2025
100%
This company
Bio-Fields
Equity €3.8m
Loss €173,238 in 2025
Capital
- Capital
- €3,554,250
- Shares
- 10,155 in the 2025 annual accounts
- Contribution per share
- €350
- Equity per share
- €373 in 2025
- Source
- deed of 15-09-2020
Owners through the years
as the annual accounts name themOwners as a list
-
- 2023 to 2024: 100%
-
- 2020 to 2021: 42.86%
-
- 2020 to 2021: 42.21%
-
- 2020: 14.28%
Source: lists of holdings in the owners' accounts
Articles of association
- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimiteddeed of 29-01-2020 (in Dutch)
- Board ruleThese rules set how the board is made up, meets and takes decisions.
- At least 3 directorsTerm of at most 6 years“Raad van bestuur, 7-Bestuur”deed of 29-01-2020 (in Dutch)
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- 20 June at 12:00deed of 06-10-2022 (in Dutch)
Capital transactions
Shareholders according to the deeds
Stated in the deed
deed of 30-05-2022 ↗
- all shares
After the capital increase
deed of 15-09-2020 ↗
- €54,250
Stated in the deed
deed of 15-09-2020 ↗
- 1,428 shares
- 4,286 shares
- 4,286 shares
- 155 shares
At incorporation
deed of 29-01-2020 ↗
- founder
- founder
- founder
Capital over time
- 15-09-2020 Capital increase of €54,250 · to €3,554,250 · 155 new shares at €350 per share, 1.5% of the 10,155 shares after the increase
- 29-01-2020 Incorporation · €3,500,000 · 10,000 shares